FOXD4 inhibitors refer to a class of chemical compounds that specifically target and modulate the activity of the FOXD4 transcription factor. FOXD4, a member of the forkhead box (FOX) family of transcription factors, plays a critical role in regulating gene expression involved in cell differentiation, proliferation, and survival. The inhibitors are designed to bind to FOXD4, disrupting its ability to interact with DNA or other proteins, thus altering its regulatory function. Inhibition of FOXD4 can impact various cellular processes such as the transcription of genes involved in development, immune response, and cellular maintenance. The precise mechanism of inhibition may involve direct binding to the DNA-binding domain of FOXD4 or interference with its interaction with co-factors that are essential for its regulatory activity.
Structurally, FOXD4 inhibitors can vary widely, encompassing small molecules, peptides, and other synthetic compounds that are engineered to target specific regions of the FOXD4 protein. These compounds are often identified and optimized through high-throughput screening methods and structure-based design, using the three-dimensional structure of the FOXD4 protein to guide the development of potent inhibitors. Key characteristics of effective FOXD4 inhibitors include high specificity for the target protein, strong binding affinity, and the ability to penetrate cellular membranes to reach intracellular targets. Their interaction with FOXD4 must be carefully balanced to ensure that they specifically inhibit FOXD4 without off-target effects on other forkhead box proteins, which share similar structural motifs.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $180.00 $610.00 | 4 | |
GSK-3β inhibitor that can enhance Wnt signaling, potentially upregulating FOXD4 which is known to be modulated by Wnt activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor that can downregulate AKT signaling, potentially affecting FOXD4 expression or activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor that can alter MAPK/ERK signaling, leading to changes in transcription factor dynamics including FOXD4. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
TGF-β receptor inhibitor that can modulate SMAD signaling, potentially impacting FOXD4 expression. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
ROCK inhibitor that can affect actin cytoskeleton dynamics and influence transcription factor localization including FOXD4. | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $96.00 $292.00 | 27 | |
Inhibitor of Wnt production that can decrease Wnt signaling, potentially lowering FOXD4 activity. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $36.00 $117.00 $525.00 | 26 | |
Tankyrase inhibitor that stabilizes Axin and inhibits Wnt signaling, possibly reducing FOXD4 expression. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
γ-secretase inhibitor that can decrease NOTCH signaling, potentially altering FOXD4 regulation. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor that can modify AP-1 activity and thereby alter transcription regulation including FOXD4 expression. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
MEK inhibitor that can decrease ERK signaling, possibly affecting FOXD4 expression or function. | ||||||